Company CVAbout Chandra Bhagat Pharma Ltd 
Chandra Bhagat Pharma Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name "Chandra Bhagat Pharma Private Limited" at Mumbai on March 10, 2003. Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to "Chandra Bhagat Pharma Limited" on March 20, 2019. The Company incorporated in March, 2003 by Mr. Hemant Bhagat and Late. Shree Chandravadan Bhagat.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 7.55 Cr
Number of Shares
75.45 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
12-Feb-2020
75.45
7.55
2000000
10
Public Issue
30-Aug-2019
55.45
5.55
182000
10
Right Issues
22-Jul-2019
53.63
5.36
4692674
10
Bonus Allotment
30-Mar-2019
6.7
0.67
133332
10
Right Issues
25-Jun-2018
5.37
0.54
119050
10
Right Issues
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 1 FIIs (0.61%)
Promoter with highest holding
Hemant Chandravadan Bhagat (35.5%)
Highest Public shareholder
Team Anamika Algo Limited (7.94%)
Individual Investors Holdings
11.84%
Board of Directors
Management
Designation
Remuneration
Hemant C Bhagat
Chairman & Managing Director
9.6 lacs
Pranav H Bhagat
Whole-time Director
9.0 lacs
Prachi Pranav Bhagat
Director & CFO
0
Ravindra Gajanan Awati
Independent Director
0
Abha Praveen Doshi
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Pharma & API Goods
65.2963
0%
Purchase of Pharma & API Goods
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
Pharmaceuticals & Biotechnology
INR 29 Cr (Micro Cap)
31.00
28
0.00%
0.61
2.83%
0.96
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
